Teleflex (NYSE:TFX) Issues Earnings Results, Beats Expectations By $0.16 EPS

Teleflex (NYSE:TFXGet Rating) posted its quarterly earnings results on Thursday. The medical technology company reported $2.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.72 by $0.16, MarketWatch Earnings reports. The company had revenue of $641.70 million during the quarter, compared to the consensus estimate of $631.89 million. Teleflex had a net margin of 17.28% and a return on equity of 17.74%. The company’s revenue for the quarter was up 1.2% on a year-over-year basis. During the same period last year, the firm earned $2.87 EPS. Teleflex updated its FY22 guidance to $13.70-14.30 EPS.

Shares of TFX traded down $9.88 during trading hours on Friday, reaching $285.62. 442,252 shares of the company traded hands, compared to its average volume of 303,911. The company has a quick ratio of 1.40, a current ratio of 2.10 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $13.40 billion, a PE ratio of 27.76, a price-to-earnings-growth ratio of 1.74 and a beta of 1.06. Teleflex has a fifty-two week low of $280.69 and a fifty-two week high of $428.36. The stock has a fifty day simple moving average of $337.17 and a 200 day simple moving average of $332.41.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 15th. Investors of record on Monday, March 7th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date was Friday, March 4th. Teleflex’s payout ratio is currently 13.22%.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Toroso Investments LLC boosted its stake in shares of Teleflex by 21.9% during the fourth quarter. Toroso Investments LLC now owns 813 shares of the medical technology company’s stock valued at $267,000 after acquiring an additional 146 shares during the last quarter. JustInvest LLC acquired a new stake in Teleflex in the 4th quarter worth about $270,000. MML Investors Services LLC boosted its stake in Teleflex by 26.3% in the 4th quarter. MML Investors Services LLC now owns 1,388 shares of the medical technology company’s stock worth $456,000 after buying an additional 289 shares during the last quarter. LPL Financial LLC boosted its stake in Teleflex by 8.6% in the 3rd quarter. LPL Financial LLC now owns 1,823 shares of the medical technology company’s stock worth $686,000 after buying an additional 144 shares during the last quarter. Finally, Vident Investment Advisory LLC boosted its stake in Teleflex by 50.2% in the 4th quarter. Vident Investment Advisory LLC now owns 2,019 shares of the medical technology company’s stock worth $663,000 after buying an additional 675 shares during the last quarter. 91.86% of the stock is currently owned by institutional investors and hedge funds.

Several equities analysts recently issued reports on TFX shares. Zacks Investment Research cut Teleflex from a “hold” rating to a “sell” rating and set a $373.00 price objective for the company. in a report on Friday, April 1st. Piper Sandler upped their target price on Teleflex from $320.00 to $335.00 in a report on Thursday, February 24th. Morgan Stanley lowered their target price on Teleflex from $383.00 to $378.00 and set an “equal weight” rating on the stock in a report on Friday, February 25th. Truist Financial lowered their target price on Teleflex from $370.00 to $340.00 in a report on Friday. Finally, StockNews.com started coverage on Teleflex in a report on Thursday, March 31st. They issued a “buy” rating on the stock. One research analyst has rated the stock with a sell rating, four have given a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $394.58.

About Teleflex (Get Rating)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Recommended Stories

Earnings History for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.